Noscendo operates as a diagnostics company.
Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 16, 2022 | Series Unknown | — | 1 | — | — | Detail |
Apr 23, 2020 | Series A | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SquareOne | — | Series Unknown |